Avalo Therapeutics, Inc.

AVTX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001534120

SEC filings (opens in a new tab)

In the last 90 days, Avalo Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $1.31B in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Avalo Therapeutics, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021 All holders in Q1 2021

13F holders of AVTX: Q1 2021 compared with Q2 2021
Measure	Q1 2021	Q2 2021	Change
Holders	70	71	+1
Shares	59.8M	66.8M	+7.00M (+11.7%)
Value	$180.4M	$218.1M	+$37.7M (+20.9%)

New holders (11)

Institutions that held Avalo Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to AVTX in Q2 2021
Institution	Shares	Value	% of portfolio
STRS Ohio	64,200	$209.0K	0.00%
Virtu Financial LLC	57,797	$189.0K	0.02%
Citadel Advisors LLC	24,264	$79.0K	0.00%
D. E. Shaw & Co., Inc.	19,238	$63.0K	0.00%
Commonwealth Equity Services, LLC	13,533	$44.0K	0.00%
Cambridge Investment Research Advisors, Inc.	10,400	$34.0K	0.00%
Avantax Planning Partners, Inc.	10,000	$33.0K	0.00%
Washington Trust Co	3,000	$10.0K	0.00%
Advisor Group Holdings, Inc.	500	$2.00K	0.00%
Navigation Wealth Management, Inc.	300	$1.00K	0.00%
Sara-Bay Financial	48,645	–	–

Sold out (10)

Institutions that held Avalo Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of AVTX in Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
Sio Capital Management, LLC	552,241	$1.67M
Renaissance Technologies LLC	284,793	$860.0K
Cubist Systematic Strategies, LLC	18,916	$57.0K
Prudential Financial Inc	10,494	$32.0K
Jane Street Group, LLC	10,289	$31.0K
Bank of Montreal	1,369	$4.00K
Federated Hermes, Inc.	149	$1.00K
Point72 Hong Kong Ltd	90	$0
Squarepoint Ops LLC	25,472	$0
RMR Wealth Builders	32	$0